UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

Journal of Nuclear Medicine, 2018-01, Vol.59 (1), p.66-74

2018

Volltextzugriff (PDF)

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors

Pancreas, 2020-08, Vol.49 (7), p.863-881

2020

Volltextzugriff (PDF)

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax

Journal of surgical oncology, 2020-12, Vol.122 (8), p.1821-1826

2020

Volltextzugriff (PDF)

Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy

JCO oncology practice, 2022-12, Vol.18 (12), p.e1935-e1942

2022

Volltextzugriff (PDF)

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1359-1369

2023

Volltextzugriff (PDF)

Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels

Journal of clinical oncology, 2016-06, Vol.34 (18), p.2141-2147

2016

Volltextzugriff (PDF)

Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients

Journal of Nuclear Medicine, 2024-03, Vol.65 (3), p.340-348

2024

Volltextzugriff (PDF)

The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas

Seminars in oncology, 2013-02, Vol.40 (1), p.100-108

2013

Volltextzugriff (PDF)

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Annals of surgical oncology, 2024-04, Vol.31 (4), p.2337-2348

2024

Volltextzugriff (PDF)

Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes

Annals of surgery, 2024-01

2024

Volltextzugriff (PDF)

Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment

Annals of surgery, 2023-11, Vol.278 (5), p.e1063-e1067

2023

Volltextzugriff (PDF)

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI : Journal of the National Cancer Institute, 2023-09, Vol.115 (9), p.1001-1010

2023

Volltextzugriff (PDF)

Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors

Hematology/oncology clinics of North America, 2016-02, Vol.30 (1), p.119-133

2016

Volltextzugriff (PDF)

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Journal of Nuclear Medicine, 2020-08, Vol.61 (8), p.1094-1095

2020

Volltextzugriff (PDF)

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition

PloS one, 2019-06, Vol.14 (6), p.e0217399

2019

Volltextzugriff (PDF)

Reply to ‘H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines’

Nature genetics, 2019-10, Vol.51 (10), p.1427-1428

2019

Volltextzugriff (PDF)

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Journal of Nuclear Medicine, 2020-02, Vol.61 (2), p.222-227

2020

Volltextzugriff (PDF)

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

The Journal of nuclear medicine (1978), 2020-02, Vol.61 (2), p.222-227

2020

Volltextzugriff (PDF)

Cytological features contributing to the misclassification of pancreatic neuroendocrine tumors

Journal of the American Society of Cytopathology JASC, 2016-09, Vol.5 (5), p.266-276

2016

Volltextzugriff (PDF)

Cancer Clinical Trials in Africa-An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials

JCO global oncology, 2021-12, Vol.7 (7), p.1358-1363

2021

Volltextzugriff (PDF)

Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

The oncologist (Dayton, Ohio), 2013-05, Vol.18 (5), p.525-532

2013

Volltextzugriff (PDF)

Systemic therapy for advanced pancreatic neuroendocrine tumors: an update

Journal of the National Comprehensive Cancer Network, 2012-06, Vol.10 (6), p.777-783

Reidy-Lagunes, Diane L

2012

Volltextzugriff (PDF)

Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19

JCO oncology practice, 2021-09, Vol.17 (9), p.e1278-e1285

2021

Volltextzugriff (PDF)

Thymidylate synthase expression in high-grade neuroendocrine and non-small cell lung cancer histotypes-is it ready for primetime?

Journal of surgical oncology, 2010-07, Vol.102 (1), p.10-10

Reidy-Lagunes, Diane

2010

Volltextzugriff (PDF)

Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: added value or an anachronism?

Journal of clinical oncology, 2011-01, Vol.29 (3), p.e74-e75

2011

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)

Publikationsform

Artikel
(104)
Buchkapitel
(2)

Sprache

Englisch
(106)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(60)
Humans
(43)
Oncology
(42)
Neuroendocrine Tumors
(28)
Tumors
(18)
Neuroendocrine Tumors - Drug Therapy
(14)
Patients
(13)
Neuroendocrine Tumors - Pathology
(12)
Cancer
(11)
Medicine
(11)
Metastases
(11)
Pancreatic Neoplasms - Drug Therapy
(10)
Surgery
(9)
Everolimus
(8)
Medicine & Public Health
(8)
Metastasis
(8)
Antineoplastic Agents - Therapeutic Use
(7)
Pancreatic Neoplasms - Pathology
(7)
Radiology, Nuclear Medicine & Medical Imaging
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax

Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels

Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients

The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas

Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes

Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition

Reply to ‘H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines’

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Cytological features contributing to the misclassification of pancreatic neuroendocrine tumors

Cancer Clinical Trials in Africa-An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials

Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

Systemic therapy for advanced pancreatic neuroendocrine tumors: an update

Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19

Thymidylate synthase expression in high-grade neuroendocrine and non-small cell lung cancer histotypes-is it ready for primetime?

Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: added value or an anachronism?

Aktive Filter

Suchergebnisse filtern